Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NasdaqCM - Nasdaq Real Time Price USD

AquaBounty Technologies, Inc. (AQB)

Compare
0.6422
+0.0309
+(5.05%)
As of 2:01:11 PM EDT. Market Open.
Loading Chart for AQB
  • Previous Close 0.6113
  • Open 0.5900
  • Bid --
  • Ask --
  • Day's Range 0.5715 - 0.6422
  • 52 Week Range 0.4700 - 2.3100
  • Volume 41,038
  • Avg. Volume 509,905
  • Market Cap (intraday) 2.483M
  • Beta (5Y Monthly) 1.18
  • PE Ratio (TTM) --
  • EPS (TTM) -19.0600
  • Earnings Date Mar 31, 2025 - Apr 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

investors.aquabounty.com

104

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AQB

View More

Performance Overview: AQB

Trailing total returns as of 3/12/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

AQB
2.59%
S&P 500
4.57%

1-Year Return

AQB
69.12%
S&P 500
8.45%

3-Year Return

AQB
97.89%
S&P 500
33.50%

5-Year Return

AQB
98.29%
S&P 500
126.26%

Compare To: AQB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AQB

View More

Valuation Measures

Annual
As of 3/11/2025
  • Market Cap

    2.32M

  • Enterprise Value

    7.50M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.84

  • Price/Book (mrq)

    0.02

  • Enterprise Value/Revenue

    5.96

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -9.03%

  • Return on Equity (ttm)

    -53.80%

  • Revenue (ttm)

    1.26M

  • Net Income Avi to Common (ttm)

    -73.5M

  • Diluted EPS (ttm)

    -19.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    522.33k

  • Total Debt/Equity (mrq)

    5.70%

  • Levered Free Cash Flow (ttm)

    -48.82M

Research Analysis: AQB

View More

Company Insights: AQB

Research Reports: AQB

View More

People Also Watch